Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Triflupromazine hydrochloride
Cat. No.:
OB0225LY-0299
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Triflupromazine hydrochloride is a typical antipsychotic agent with antipsychotic activity and sedative effects.
Synonym:
Neoprin; Fluopromazine hydrochloride; Fluorofen; Flumazin; 1098-60-8; 2-(Trifluoromethyl)promazine; N, N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine
CAS No.:
1098-60-8
Compound CID:
5568
Formula:
C18H20ClF3N2S
Formula Weight:
388.88
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Triflupromazine hydrochloride can be used to study the mechanisms of neuropsychiatric disorders or play an important role in drug screening.
Library Information
Targets:
G protein-coupled receptors (GPCRs)
Receptors:
5-HT receptor; Autophagy receptor; Dopamine receptor; mAChR
Pathways:
GPCR/G protein; Autophagy; Neuronal signaling
Plate Number:
AOCL-4
Plate Location:
g10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 128.57 mM
